Hypothermia extends the cardioprotection by ischaemic preconditioning to coronary artery occlusions of longer duration

Cardiovascular Research
M A van den DoelP D Verdouw

Abstract

To test the hypothesis that mild hypothermia potentiates the cardioprotection afforded by ischaemic preconditioning so that infarct size limitation can be obtained after coronary artery occlusion (CAO) durations which exceed the cardioprotective range (> 90 min) of either hypothermia or ischaemic preconditioning alone. Four groups of anaesthetized rats were subjected to different durations of CAO: (i) normothermia (N, 36.5-37.5 degrees C, n = 29), (ii) normothermia + ischaemic preconditioning (N + IP, 15 min CAO followed by 10 min of reperfusion, n = 35), (iii) hypothermia (H, 30-31 degrees C, n = 31) and (iv) hypothermia + ischaemic preconditioning (H + IP, n = 24). Infarct size (IA/AR) was determined after 3 hours of reperfusion using trypan blue to delineate the area at risk (AR) from non-risk region and nitroblue tetrazolium to delineate infarcted area (IA) from viable myocardium. In N the CAO duration versus infarct size relation had a sigmoid shape with virtually no infarction occurring at 15 min CAO and 56 +/- 5% of the area at risk being infarcted at 30 min CAO reaching a plateau of 71 +/- 2% at 60 min CAO. Hypothermia produced a rightward shift of the relation resulting in an approximately 15 min delay in onset of infa...Continue Reading

Citations

Sep 24, 2005·Basic Research in Cardiology·Michael MaengHenning R Andersen
Apr 7, 2011·Basic Research in Cardiology·Karin Przyklenk, Peter Whittaker
Jun 17, 2011·Basic Research in Cardiology·Renaud TissierJames M Downey
Jul 14, 2010·Cardiovascular Research·Renaud TissierAlain Berdeaux
Dec 2, 2011·Cardiovascular Research·Renaud TissierAlain Berdeaux
Apr 27, 2002·Heart Disease·S L Hale, R A Kloner
Sep 30, 2004·Journal of Cardiovascular Pharmacology·Erik LipsicRegien G Schoemaker
Mar 2, 2013·Journal of Hypertension·Mariusz K SzymanskiRegien G Schoemaker
Jul 23, 1999·Annals of the New York Academy of Sciences·S de ZeeuwP D Verdouw
Feb 28, 2007·BMC Cardiovascular Disorders·Goran K OlivecronaDavid Erlinge
Nov 21, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·David ErlingeGöran K Olivecrona
Feb 28, 2014·Pflügers Archiv : European journal of physiology·Dirk J DunckerJolanda van der Velden
Oct 10, 2003·Scandinavian Cardiovascular Journal : SCJ·Michael MaengHenning Rud Andersen
May 17, 2005·British Journal of Pharmacology·Olivier C ManintveldDirk J Duncker
Feb 6, 2007·Journal of the American College of Cardiology·Renaud TissierJames M Downey
Jan 13, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Edward J Calabrese
Jul 5, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Lys DarberaRenaud Tissier
Oct 4, 2016·Archives of Cardiovascular Diseases·Matthias KohlhauerRenaud Tissier
Jun 18, 2011·Experimental Biology and Medicine·Olivier C ManintveldDirk J Duncker
Aug 17, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Boris Z SimkhovichRobert A Kloner
Dec 15, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Sharon L Hale, Robert A Kloner
Dec 31, 2015·European Heart Journal. Acute Cardiovascular Care·Luis O ChavezJoseph Varon
Apr 27, 2017·Therapeutic Hypothermia and Temperature Management·Junjie GuoJunbo Ge
Nov 24, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Olivier C ManintveldDirk J Duncker
Mar 3, 2004·The Journal of Pharmacology and Experimental Therapeutics·David A LiemDirk J Duncker
Mar 19, 2020·Cells·Carolina BalbiSveva Bollini
Apr 30, 2019·Neurological Research·Yun HanXiaokun Geng
Apr 21, 1999·Journal of Cardiovascular Electrophysiology·S L Hale, R A Kloner
Jun 14, 2002·American Journal of Physiology. Heart and Circulatory Physiology·David A LiemDirk J Duncker
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Qun ChenDavid F Stowe
Jun 11, 1999·The American Journal of Physiology·S L Hale, R A Kloner
Oct 16, 2004·American Journal of Physiology. Heart and Circulatory Physiology·David A LiemDirk J Duncker
Jul 4, 2009·Journal of Applied Physiology·Monique C de Waard, Dirk J Duncker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.